To validate the iTRAQ results, ELISA was used to measure four candidate proteins, A1AT, PRDX2, PON1, and CRP, in the serum of another 20 HCC patients and 20 healthy controls. The gene discussed is PON1; the disease is hepatocellular carcinoma.